180 related articles for article (PubMed ID: 2777859)
1. Hyperthermic regional perfusion using membrane- instead of bubble-oxygenators. An experimental and clinical study.
van Os J; Schraffordt Koops H; Oldhoff J; Wildevuur CR
J Cardiovasc Surg (Torino); 1989; 30(4):523-32. PubMed ID: 2777859
[TBL] [Abstract][Full Text] [Related]
2. Improved tissue perfusion during pressure-regulated hyperthermic regional isolated perfusion in dogs.
Fontijne WP; de Vries J; Mook PH; Elstrodt JM; Oosterhuis JW; Schraffordt Koops H; Oldhoff J; Wildevuur CR
J Surg Oncol; 1984 May; 26(1):69-76. PubMed ID: 6727389
[TBL] [Abstract][Full Text] [Related]
3. Membrane versus bubble oxygenator in hyperthermic regional perfusion: a prospective randomized clinical study.
Huber R; Mennicke C; Heitmann KU; Helling HJ; Huber PM
Eur Surg Res; 1994; 26(4):210-20. PubMed ID: 7957457
[TBL] [Abstract][Full Text] [Related]
4. Improved tissue perfusion during pressure regulated hyperthermic regional isolated perfusion. A clinical study.
Fontijne WP; Mook PH; Koops HS; Oldhoff J; Wildevuur CR
Cancer; 1985 Apr; 55(7):1455-61. PubMed ID: 3978538
[TBL] [Abstract][Full Text] [Related]
5. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.
Hafström L; Hugander A; Jönsson PE; Westling H; Ehrsson H
Cancer Treat Rep; 1984 Jun; 68(6):867-72. PubMed ID: 6733699
[TBL] [Abstract][Full Text] [Related]
6. Modification of human tumour and normal tissue pH during hyperthermic and normothermic antiblastic regional isolation perfusion for malignant melanoma: a pilot study.
van de Merwe SA; van den Berg AP; Kroon BB; van den Berge AW; Klaase JM; van der Zee J
Int J Hyperthermia; 1993; 9(2):205-17. PubMed ID: 8468505
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bubble and membrane oxygenators in short and long perfusions.
Clark RE; Beauchamp RA; Magrath RA; Brooks JD; Ferguson TB; Weldon CS
J Thorac Cardiovasc Surg; 1979 Nov; 78(5):655-66. PubMed ID: 491720
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators.
von Segesser LK; Turina M
J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320
[TBL] [Abstract][Full Text] [Related]
9. Circuit and protocol for hypoxic hyperthermic isolated limb perfusion to treat malignant melanoma.
Innet LM; Haripershad V; Van Den Berg J; Cooper L
Perfusion; 2001 Jul; 16(4):325-30. PubMed ID: 11486853
[TBL] [Abstract][Full Text] [Related]
10. [Extra-corporeal circulation. Experimental study. Comparative study of various oxygenators (author's transl)].
Loisance D; Escourrou P; Lienhart A; Bessou JP; Rotman N; Lerebours G; Cachera JP
J Chir (Paris); 1978; 115(8-9):457-63. PubMed ID: 721917
[TBL] [Abstract][Full Text] [Related]
11. Isolated hindlimb perfusion in dogs: the effect of perfusion pressures on the oxygen supply (ptO2 histogram) to the skeletal muscle.
Fontijne WP; Mook PH; Elstrodt JM; Schraffordt Koops H; Oldhoff J; Wildevuur CR
Surgery; 1985 Mar; 97(3):278-84. PubMed ID: 3975848
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb.
Rauschecker HF; Foth H; Michaelis HC; Horst F; Gatzemeier W; Willenbrock C; Voth E; Kahl GF
Cancer Chemother Pharmacol; 1991; 27(5):379-84. PubMed ID: 1998997
[TBL] [Abstract][Full Text] [Related]
13. A prospective comparison of bubble and membrane oxygenators in short and long perfusions.
Dhumale R; Lake S; Pepper J
Eur J Cardiothorac Surg; 1987; 1(1):20-2. PubMed ID: 3273207
[TBL] [Abstract][Full Text] [Related]
14. Development of the oxygenator: past, present, and future.
Iwahashi H; Yuri K; Nosé Y
J Artif Organs; 2004; 7(3):111-20. PubMed ID: 15558331
[TBL] [Abstract][Full Text] [Related]
15. Postperfusion lung syndrome. Comparison of Travenol bubble and membrane oxygenators.
Byrick RJ; Noble WH
J Thorac Cardiovasc Surg; 1978 Nov; 76(5):685-93. PubMed ID: 29994
[TBL] [Abstract][Full Text] [Related]
16. [Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
Kettelhack C; Hohenberger P; Schlag PM
Dtsch Med Wochenschr; 1997 Feb; 122(7):177-81. PubMed ID: 9072487
[TBL] [Abstract][Full Text] [Related]
17. Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique.
Cattel L; Buffa E; De Simone M; Cesana P; Novello S; Dosio F; Ceruti M
Anticancer Res; 2001; 21(3C):2243-8. PubMed ID: 11501854
[TBL] [Abstract][Full Text] [Related]
18. Technical aspects of isolation extremity perfusion: experimental studies and clinical experience.
Ghussen F; Krüger I
J Invest Surg; 1989; 2(4):487-96. PubMed ID: 2518674
[TBL] [Abstract][Full Text] [Related]
19. Alteration of red cell deformability during extracorporeal bypass: membrane v bubble oxygenator.
Hakoshima A; Goto H; Abe K; Benson KT; Moran JF; Arakawa K
J Cardiothorac Anesth; 1989 Apr; 3(2):189-92. PubMed ID: 2519944
[TBL] [Abstract][Full Text] [Related]
20. Desflurane as a marker of limb-to-systemic leak during hyperthermic isolated limb perfusion.
Stanley G; Sundarakumaran R; Crowley R; Kavanah M
Anesthesiology; 2000 Aug; 93(2):574-6. PubMed ID: 10910485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
